Statements (64)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
biotechnology company
|
| gptkbp:access |
improves patient access to tests
|
| gptkbp:acquisition |
gptkb:Exact_Sciences_Corporation
|
| gptkbp:advertising |
focus on oncology
|
| gptkbp:analyzes |
utilizes data analysis in diagnostics
|
| gptkbp:awards |
various industry awards
|
| gptkbp:businessModel |
diagnostic testing business model
|
| gptkbp:clinicalTrials |
participates in clinical trials
clinical validation of tests conducted for various cancers influences treatment guidelines integrates into clinical pathways measures clinical impact of tests provides clinical evidence for tests |
| gptkbp:collaborations |
with academic institutions
engages in research collaborations develops healthcare partnerships |
| gptkbp:community_service |
influences healthcare policies
supports patient advocacy initiatives provides patient support services focus on cancer biomarkers collects_patient_feedback |
| gptkbp:competitors |
conducts market research
|
| gptkbp:current_use |
monitors test utilization rates
|
| gptkbp:developer |
continues test development
|
| gptkbp:employees |
approximately 1,000
|
| gptkbp:enrollment |
analyzes patient demographics
|
| gptkbp:examinationType |
follows test guidelines
|
| gptkbp:feedback |
aims to improve patient outcomes
aims to improve health outcomes focuses on improving clinical outcomes |
| gptkbp:focus |
molecular diagnostics
|
| gptkbp:founded |
2000
|
| gptkbp:founder |
gptkb:Kimberly_Popovits
|
| gptkbp:geneticDiversity |
offers genetic counseling services
|
| gptkbp:hasService |
develops diagnostic tests
|
| gptkbp:headquarters |
gptkb:Redwood_City,_California
|
| gptkbp:healthcare |
provides patient education resources
works with healthcare providers contributes to healthcare innovation |
| https://www.w3.org/2000/01/rdf-schema#label |
Genomic Health
|
| gptkbp:impact |
improving treatment decisions
|
| gptkbp:industry |
healthcare
|
| gptkbp:investmentFocus |
venture capital firms
|
| gptkbp:is_evaluated_by |
high test accuracy
|
| gptkbp:market |
leader in cancer diagnostics
|
| gptkbp:notableEvent |
Oncotype DX
|
| gptkbp:partnerships |
various healthcare organizations
|
| gptkbp:patentCitation |
numerous patents in genomics
|
| gptkbp:publications |
published research studies
|
| gptkbp:receives_funding_from |
works on test reimbursement issues
|
| gptkbp:regulatoryCompliance |
FDA_approved_tests
|
| gptkbp:reliability |
high test reliability
|
| gptkbp:research |
gptkb:Dr._David_R._Smith
engages with scientific community |
| gptkbp:research_focus |
personalized medicine
|
| gptkbp:revenue |
$300 million (2018)
|
| gptkbp:services |
cancer diagnostics
|
| gptkbp:targetMarket |
breast cancer patients
expanded internationally colon cancer patients prostate cancer patients |
| gptkbp:technology |
genomic testing
|
| gptkbp:website |
www.genomichealth.com
|